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Abstract Nuclear magnetic relaxation dispersion (NMRD) profiles are essential
tools to evaluate the efficiency and investigate the properties of magnetic com-
pounds used as contrast agents for magnetic resonance imaging (MRI), namely
gadolinium chelates and superparamagnetic iron oxide particles. These curves
represent the evolution of proton relaxation rates with the magnetic field. NMRD
profiles are unparalleled to probe extensively the spectral density function involved
in the relaxation of water in the presence of the paramagnetic ion or the magnetic
nanoparticles. This makes such profiles an excellent test of the adequacy of a
theoretical relaxation model and allow for a predictive approach to the development
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and optimization of contrast agents. From a practical point of view they also allow
to evaluate the efficiency of a contrast agent in a certain range of magnetic fields.
Nowadays, these curves are recorded with commercial fast field cycling devices,
often limited to a maximum Larmor frequency of 40 MHz (0.94 T). In this article,
relaxation data were acquired on a wide range of magnetic fields, from 3.5 9 10-4
to 14 T, for a gadolinium-based contrast agent and for PEGylated iron oxide
nanoparticles. We show that the low-field NMRD curves can be completed with
high-field data obtained on a shuttle apparatus device using the superconductive
magnet of a high-field spectrometer. This allows a better characterization of the
contrast agents at relevant magnetic fields for clinical and preclinical MRI, but also
refines the experimental data that could be used for the validation of relaxation
models.
1 Introduction
Nuclear magnetic resonance (NMR) relaxometry consists in the measurement of the
relaxation times (T1, T2) of a nucleus observable in NMR as a function of the
magnetic field. The dependence of the relaxation rates (R1 = 1/T1 and R2 = 1/T2)
with the magnetic field bears important information since it gives access to the
spectral density and thus to the mechanism of relaxation [1, 2]. This allows one to
probe the molecular dynamics of different systems such as proteins, polymers, and
water trapped in porous systems. Relaxometry provides sufficiently extensive
experimental datasets so that the relaxation mechanisms can be determined in yet
poorly characterized systems containing magnetic entities. This is especially true for
water proton relaxation induced by paramagnetic ions [3] and superparamagnetic
particles used as contrast agents for magnetic resonance imaging [4]. The curves
representing the evolution of relaxation rates with the magnetic field are called
nuclear magnetic relaxation dispersion (NMRD) profiles. The term ‘‘dispersion’’
indicates that for many systems the rates decrease for increasing fields, which
reflects the dispersion of the spectral density function for increasing Larmor
frequencies. Experimentally the R1 NMRD curves are often measured with the fast
field-cycling (FFC) technique, and can be complemented by conventional R1
measurements on NMR devices working at a single field. Recording R2 rates
requires the application of a series of refocusing radiofrequency pulses, which is
difficult on fast field-cycling systems. R2 NMRD profiles are thus obtained through
measurements on a series of instruments, relaxometers and spectrometers. The use
of high field spectrometers already allows to probe the high field region of the
NMRD profiles [5–9]. However, it necessitates the access to numerous instruments
and can be time consuming.
Using FFC, the sample is submitted to sudden changes of magnetic field from the
polarization field Bpol to the relaxation field Brel, which causes relaxation, without
using any excitation pulse. The detection is always done at the same field Bdet,
whatever the relaxation field Brel is. This allows to use a single probe tuned at the
resonance frequency of the detection field Bdet, where a 90 pulse has to be used to
record a free induction decay. In available commercial devices, called FFC-
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relaxometers, the change in magnetic field is caused by a change in the electrical
current circulating in an electromagnet. The technique is demanding for both the
magnet and its cooling system. Indeed the Joule effect is considerable and the heat
produced at the magnet must be evacuated through an appropriate cooling system to
ensure magnetic field stability. As a consequence, the maximum electromagnet field
accessible is limited: magnetic fields can be as low as 0.23 mT but often limited to 1
T. However, the field change can be really fast (*1 ms) which allows the
measurement of short T1. In order to reach higher fields, the sample shuttle
technique can be used: it consists in moving the sample in different regions of the
stray field of a strong superconducting magnet, usually the magnet of a commercial
high-field NMR spectrometer. The motion of the shuttle can be driven by a
pneumatic system [10–12] or a motorized apparatus [13, 14]. The speed at which the
field can be changed is limited by the motion of the sample and thus slower than in
FFC-relaxometers (*50–100 ms) so that the measurement of short T1 is challeng-
ing. However, the maximum magnetic field accessible is limited to the magnetic
field of a high-field NMR magnet. In the case of contrast agents, this covers, in
principle, all fields accessible to MRI. Excellent descriptions of the FFC techniques
and of some applications can be found in the literature [15–17].
The development of the theories describing the relaxation induced by param-
agnetic and superparamagnetic contrast agents is closely related to the measurement
of NMRD profiles of aqueous suspensions of these magnetic systems. Indeed theses
curves constitute unique experimental data to test the adequacy of the theoretical
models through a simple fitting of the NMRD profile. From a fundamental point of
view, T1 data at fields larger than 1 T can therefore be necessary to test/develop
relaxation models for magnetic contrast agents.
From a more practical point of view, NMRD profiles of contrast agents also
provide at a glance their relaxation efficiency at different Larmor frequencies, which
is valuable for MRI at a given field. However, most new MRI systems operate at 3
T, typical small animal MRI systems operate at 7 T while some new devices reach
21 T. Such fields are not accessible to commercial FFC equipments which are often
limited to 1 T, while some recent hybrid systems using a superconducting magnet
reach 3 T. In this communication, we show that both the low-field (obtained with a
commercial device) and high-field NMRD profiles (recorded with a shuttle system)
are necessary for the evaluation of contrast agents efficiency as well as for the
development of relaxation models for magnetic contrast agents.
2 Materials and methods
Oleylamine- and PEG-coated ultra small superparamagnetic iron oxide particles
(USPIOs) were synthesized using a two-step reaction based on a modification of a
recently published method [18]. First, 1.042 g Fe(acac)3 were added to 30 mL of
oleylamine. The solution was gradually heated to 128 C at a rate of 363.5 C/h
under a N2 flow followed by a temperature increase to 180 C over a period of 1 h,
and finally heating to 270 C at a ramping rate of 396 C/h after which the heating
appliance was removed. The solution was left to cool to room temperature and the
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oleylamine-iron oxide nanoparticles precipitated upon the addition of 30 mL of
ethanol, followed by centrifugation at 9000g for 4 min. The supernatant was
discarded and the process repeated with another 35 mL of ethanol, then a further
56 mL. The resulting particles had a core of 5.2 ± 0.7 nm, based on the statistical
analysis of 100 particles observed by transmission electron microscopy (TEM). The
process of functionalization with PEG(5)-BP [polyethylene glycol (5 kDa)-bispho-
sphonate] allowed for high yields to be reached in a short time and at room
temperature. First, 1 mg oleylamine-coated USPIOs and 10 mg PEG(5)-BP were
added to 1 mL of dichloromethane in an open glass vial, and the mixture was
sonicated for*15 min until the solvent had evaporated. 2 mL of water were added
to the remaining residue resulting in a clear brown solution. The mixture was
washed with 2 mL of hexane to remove the oleylamine, followed by removal of
hexane by evaporation under a N2 flow. This process was repeated two more times.
The final mixture was filtered through a 0.2 lm hydrophilic polytetrafluoroethylene
filter, followed by several cycles of washing/concentrating using a Vivaspin two
centrifugal filter (30 kDa molecular weight cut off) using water to remove excess
PEG(5)-BP leaving an amber dispersion of PEG(5)-BP-USPIOs. After PEGylation,
there was no significant difference in the core size of the PEG(5)-BP-USPIOs
(5.2 ± 0.6 nm based on the statistical analysis of 100 particles), and the
hydrodynamic diameter, measured using dynamic light scattering (DLS), was
30 ± 9 nm.
GadoSpinTM P was purchased from Miltenyi Biotec GmbH (Germany). It is a
polymeric gadolinium-based contrast agent (intended for MRI of small animals)
containing several gadolinium chelates (Gd-DTPA-pentaamide) bound to a polymer
backbone. The synthesis protocol is described in [19]. The molecular weight of the
molecule is about 200 kDa. The lyophilized compound was reconstituted with
850 lL of physiological saline solution, which provided a final Gd3? concentration
of 20 mM. The stock solution was further diluted in the same buffer to reach a final
Gd3? concentration of 0.5 mM for sample shuttling measurements.
Low-field NMRD profiles (T1) of aqueous suspensions were measured from
0.015 to 40 MHz with a Spinmaster FFC relaxometer (STELAR, Mede, Italy) at
25 C using 600 lL of suspensions in a dedicated NMR tube.
The high-field parts of the NMRD profiles were recorded on a Bruker Avance
IIIHD 600 MHz spectrometer equipped with a pneumatic sample shuttle already
described in detail [11, 12]. The magnetic field above the magnetic center was
measured in steps of 1 mm using a homemade device with two calibrated triple-axes
Hall probes (Senis) with a precision of 0.1 %. A CH3A10mE3D transducer was
used for measurements from 0.05 to 2 T, while a 03A05F-A20T0K5Q transducer
was used between 1 and 13 T. A systematic error of up to 3 % cannot be excluded
and was reported on Figs. 1 and 2. The magnetic field for relaxation was constant
with 1 % for all measurements carried out at each magnetic field (this corresponds
to a displacement of the top position by less than 1 mm). The system includes a
triple-resonance (1H, 13C, 15N) probe with a z-gradient. The low volume of the
sample (100 lL) and the fact that detection on the proton channel is performed with
the outer coil make this system mostly immune to radiation damping. Longitudinal
relaxation rates at 14.1 T were measured using saturation recovery experiments. All
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Fig. 1 T1 NMRD profile of PEGylated iron oxide nanoparticles at 25 C
Fig. 2 T1 NMRD profile of Gadospin
TM at 25 C
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other relaxation rates were measured with a sequence given as supporting
information (Fig. S1). After a 5 s delay for polarization at 14.1 T, the longitudinal
polarization is inverted every other scan before the transfer to the desired low-field
spot, the sample shuttle is transferred back to 14.1 T after the relaxation delay for
detection (see Fig. S1). The measured intensity can be fitted by a single exponential,
which decays towards zero. In the case of the Gadospin study, two sub-spectra (with
and without inversion at high field) were fitted independently, as the measurement
of signal differences was challenging in the absence of lock (no D2O was added to
the sample). All experiments were repeated three times, error bars represent the
standard deviation of the three (six) fitted relaxation rates for USPIO (respectively,
Gadospin) samples. The error was larger for low fields because of relaxation
occurring during the transport of the sample, especially for small relaxation times.
All exponential fits were carried with the T1/T2 module of the Topspin software.
The iron and gadolinium concentrations of the samples were determined by
Inductively Coupled Plasma-Atomic Emission Spectrometry (ICP-AES) after
microwave digestion in a mixture of nitric acid and hydrogen peroxide. All the
relaxation data are presented as relaxivities r1, defined as the relaxation rate R1 = 1/
T1 normalized by the iron (or gadolinium) concentration.
3 Results and discussion
Figures 1 and 2, respectively, present the T1 NMRD profiles of PEG(5)-BP-USPIO
particles and GadospinTM paramagnetic contrast agent. For both compounds, the
data obtained at high field with the shuttle system are in good agreement with the
low-field data measured with the commercial FFC device. This can be verified in
particular by the inspection of the data obtained on both equipments between 20 and
40 MHz. This zone is crucial since it allows for a direct comparison of the results
obtained with the two techniques. The concentration used for high-field NMRDs
was smaller than for low-field NMRDs since the shuttle times are rather large
compared to the electronic switching times. As relaxation must be minimal during
these time intervals, samples with longer relaxation times must be used with the
shuttle device. It is worth noting that the 600 MHz measurement, obtained by a
conventional saturation-recovery sequence in the normal configuration of the
spectrometer, is clearly compatible with the data obtained at lower fields with the
shuttle system.
Table 1 Parameters obtained from the fits of the NMRD profiles
Iron oxide nanoparticles Msat (A/m) R (nm) sN (ns) p
All data (189 ± 5) 103 4.64 ± 0.2 1.16 ± 0.11 0.27 ± 0.5
Low field data (205 ± 4) 103 4.27 ± 0.09 0.89 ± 0.05 0.24 ± 0.5
GadospinTM sR (ns) sM (ls) sSO (ns) sV (ps) sSS (ps) qSS
0.480 ± 0.024 2.46 ± 0.05 0.13 ± 0.005 41 ± 0.4 57 ± 7 1.25 ± 0.15
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The relaxation data of the superparamagnetic nanoparticles was fitted with the
theory developed by Roch et al. [4] with a water diffusion coefficient at 25 C of
2.3 9 10-9 m/s2. The fitted parameters are provided in Table 1.
The NMRD profile of the gadolinium compound was fitted thanks to the
Solomon-Bloembergen-Morgan (SBM) inner sphere relaxation theory with addi-
tional contributions from outer sphere [3] and second sphere relaxation [20–22].
Simple Lorentzian spectral density functions were used in the SBM equations even
if for macromolecules the Lipari-Szabo´ spectral density functions could be more
appropriate [6, 23, 24]. However, this approach—using a global rotation time, a
correlation time refecting rapid local motions and a general order parameter—would
add two parameters for the fitting of the NMRD profile, for a total of 8 parameters.
Moreover, to confirm that the Lipari-Szabo´ model is adequate, additional 17O NMR
measurements would be needed. This is beyond the scope of this communication
and therefore we chose to use the Lorentzian spectral density function in the SBM
equations. It is worth noting that even the SBM equations are sometimes unable to
fit the low field part of NMRD profiles for slowly rotating systems [25]. Second
sphere relaxation was introduced in order to take into account the contribution from
water molecules of the second coordination sphere of the ion. Indeed some of the
water molecules are not freely diffusing around the complex but hydrogen bonded
to polar groups of the ligand. This latter relaxation term is not always easy to define
but was shown to be non negligible for many Mn2? and Gd3? complexes. Its
accurate description is difficult without further pH and temperature dependence
studies of the relaxation rates. Therefore, and even if it constitutes an approxima-
tion, we used the same distance of approach (0.36 nm) for the the outer and second
sphere contributions, which is a reasonable approximation for Gd3? complexes [20–
22]. As our introduction of the second sphere relaxation is only approximate, the
number of water molecules of the second sphere contributing to relaxation (qss) was
not forced to be an integer. The fixed parameters of the fit were: Spin (Gd3?) = 3.5,
number of coordinated water molecules q = 1, distance of closest approach for
inner sphere = 0.31 nm, distance of closest approach for outer sphere and second
sphere = 0.36 nm, diffusion coefficient at 25 C = 2.3 9 10-9 m/s2. As usual for
gadolinium, the scalar contribution was neglected. The fitted parameters are
provided in Table 1.
The profile of iron oxide particles was fitted using the theory of Roch et al.Msat is
the saturation magnetization of the particle, R is the radius of the particle, sN is the
Ne´el relaxation time and p is an empirical parameter related to the anisotropy of the
crystal.
The Gadospin NMRD profile was fitted with the Solomon-Bloembergen-Morgan
inner-sphere relaxation theory with additional contributions from outer-sphere and
second-sphere relaxation. sR is the rotational correlation time of Gd
3? individual
complexes, sM is the coordinated water residence time, sSO is the zero-field electron
relaxation time, sV is the correlation time associated with the electron relaxation
modulation, qSS is the number of water molecules in the second sphere and sSS the
correlation time of the interaction of Gd3? with water molecules belonging to the
second sphere.
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The high-field data show that the relaxivities of both compounds decrease at high
fields. This effect is well known—and ineluctable—for superparamagnetic particles.
Such a decrease could be moved to higher field for gadolinium-based contrast
agents by slowing down the rotational tumbling of the gadolinium complex. For
example, this is achieved by grafting gadolinium chelates to nanoparticles and
macromolecules, as dendrimers and polymers, which can even result in the
appearance of a relaxivity peak at high fields [6, 26–29]. In the case of GadospinTM,
the rotation of the complex is too fast (sR = 0.48 ns) to maintain high longitudinal
relaxivities at high fields. This indicates the high flexibility of the gadolinium
complex in the polymeric backbone, which is not beneficial in this case. From a
fundamental point of view, the agreement between theories and experimental data is
satisfactory. The long exchange time obtained from the fitting is compatible with
previous results for pentaamide derivatives [30]. In our opinion, it is clear that the
very high-field data, which are usually not included in the analysis of NMRD
profiles, contains a large amount of information, and that including them in the
fitting is more demanding for the theory. For example, a systematic deviation can be
observed between theory and experimental results at the highest fields (300 MHz
and above), for GadospinTM which could mean that the usual Lorentzian spectral
density functions are not adequate and that the Lipari-Szabo´ spectral density
functions must be used instead. Similarly, the high-field dispersion of the NMRD
profile of PEGylated superparamagnetic particles is not perfectly fitted by the Roch
model [4]. This could be caused by the size distribution of the particles, which is not
taken into account in this relaxation theory but was previously shown to influence
relaxation [31–33]. The introduction of the influence of the particles size
distribution in the NMRD fitting could be really interesting, since it would provide
an estimation of the polydispersity of the particles which is crucial for biomedical
applications. The development of such a model would require the whole NMRD
profile, and especially the high field dispersion obtained on the shuttle device.
However, even the current fitting procedure of the NMRD profile can bring
interesting information about the sample: the size obtained by the NMRD fitting is
9.28 nm while the size obtained by TEM was 5.2 nm. Moreover, the magnetization
provided by the fitting (Mv = 189000 A/m) is significantly smaller the bulk
magnetization of magnetite (Mv = 380000 A/m). This is a clear sign of clustering
of the iron oxide cores in a polymer matrix [34], which is supported by the large
hydrodynamic size (30 nm) of the system. Indeed a single core with a 5 kDa PEG
coating would present a smaller hydrodynamic size.
4 Conclusion
NMRD profiles ranging from very low fields to very high fields were measured with
a commercial fast field-cycling device and a shuttle apparatus for PEGylated
superparamagnetic iron oxide particles and a polymeric gadolinium chelate. The
agreement between the FFC and shuttle-based measurements at their intersection is
good. The data were compared to the fit of the usual relaxation theories with a rather
good agreement, even if the high-field results are not perfectly reproduced by the
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fitting. This shows that the complete NMRD profile should be used when trying to
refine relaxation theories. Indeed they bear relevant information and are therefore
more demanding for the questioned theory. Last but not least, they also allow for the
direct evaluation of the efficiency of a potential contrast agent at all fields, including
fields typical of clinical and small animal MRI.
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